Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant JEV Envelope protein E Protein, N-TrxA-His & C-His

Catalog #:   YVV25701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P32886
Protein length: Phe295-Ala794
Overview

Catalog No.

YVV25701

Expression system

E. coli

Species

Japanese encephalitis virus (strain Jaoars982) (JEV)

Protein length

Phe295-Ala794

Predicted molecular weight

73.48 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P32886

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Genome polyprotein, Envelope protein E

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Japanese encephalitis virus (strain Jaoars982) (JEV) Envelope protein E protein
References

Genotype patterns and evolutionary rates: uncovering Japanese encephalitis virus spread across Asia's climate regions., PMID:40425079

Diallyl trisulfide inhibits in vitro replication of the Japanese encephalitis virus by modulating autophagy via mTOR-dependent pathway., PMID:40413830

Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide., PMID:40267616

E3 ubiquitin ligase MARCH5 positively regulates Japanese encephalitis virus infection by catalyzing the K27-linked polyubiquitination of viral E protein and inhibiting MAVS-mediated type I interferon production., PMID:40071916

A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expression., PMID:40022449

RAB4B and Japanese encephalitis virus E protein interaction is essential for viral entry in early endosomes., PMID:40020812

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865

The zinc finger protein ZFP36L2 inhibits flavivirus infection via the 5'-3' XRN1-mediated RNA decay pathway in the replication complexes., PMID:39972499

Generation of soluble, immunoreactive recombinant JEV E protein through a simplified inclusion body extraction and refolding approach in vitro., PMID:39816339

Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14., PMID:39775684

A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses., PMID:39764453

Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review., PMID:39755947

Emerging West African Genotype Chikungunya Virus in Mosquito Virome., PMID:39715491

Integrated proteomics and connectivity map-based analysis reveal compounds with a potential antiviral effect against Japanese encephalitis virus infection in a mouse model., PMID:39710957

NS2B-D55E and NS2B-E65D Variations Are Responsible for Differences in NS2B-NS3 Protease Activities Between Japanese Encephalitis Virus Genotype I and III in Fluorogenic Peptide Model., PMID:39684391

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations., PMID:39625409

From bytes to bites: In-silico creation of a novel multi-epitope vaccine against Murray Valley Encephalitis Virus., PMID:39617074

Glycoengineered extracellular vesicles released from antibacterial hydrogel facilitate diabetic wound healing by promoting angiogenesis., PMID:39600241

An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice., PMID:39588106

The Role of Complement Activation in IgM M-Protein-Associated Neuropathies., PMID:39571136

A novel multiplexed immunoassay for surface-exposed proteins in plasma extracellular vesicles., PMID:39498678

Integrin α6-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151., PMID:39329462

The 8-oxoguanine DNA glycosylase-synaptotagmin 7 pathway increases extracellular vesicle release and promotes tumour metastasis during oxidative stress., PMID:39235072

A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge., PMID:39085247

The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer., PMID:38978304

Extracellular vesicle isolation methods identify distinct HIV-1 particles released from chronically infected T-cells., PMID:38978287

Japanese Encephalitis Virus Infection among Wild Caught Vectors Mosquitoes and Domestic Pigs in Northern West Bengal, India., PMID:38934834

The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness., PMID:38840203

Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670

[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101

Characterization of Japanese Encephalitis Virus Isolated from Persistently Infected Mouse Embryo Cells., PMID:38787050

Lipid A in outer membrane vesicles shields bacteria from polymyxins., PMID:38766978

[Changes and intervention of reactive astrocyte activation patterns in the progression of Japanese encephalitis]., PMID:38710514

Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed., PMID:38659349

Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8+T cells., PMID:38643856

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus., PMID:38618740

Molecular and serological evidence of chikungunya virus infection with high case fatality among pediatric population with acute encephalitis syndrome: first report from Eastern Uttar Pradesh, India., PMID:38557925

Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen/Deuterium Exchange., PMID:38540792

[3-Deazaadenosine (3-DAA) accelerates Japanese encephalitis virus replication and down-regulates levels of inflammatory factors in mouse and hamster cells]., PMID:38512034

Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease., PMID:38498608

Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases., PMID:38479360

Short Communication: Mosquito Histone 2A Protein Facilitate Japanese Encephalitis Virus Infection in the Mosquito., PMID:38441490

Low-temperature culture enhances production of flavivirus virus-like particles in mammalian cells., PMID:38416210

Marine Brown Algae-Derived Compounds as Potential Inhibitors of Japanese Encephalitis Virus RNA-Dependent RNA Polymerase., PMID:38393063

Isolation and identification of a duck-derived Japanese encephalitis virus and evaluation of its virulence in mice., PMID:38198922

Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF ) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology., PMID:38191961

Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis., PMID:38189894

Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies., PMID:38158550

NS2B-D55E and NS2B-E65D Variations are Responsible for Differences in NS2B-NS3 Protease Activities Between Japanese Encephalitis Virus Genotype I and III in Fluorogenic Peptide Model., PMID:38105993

Ferroptosis contributes to JEV-induced neuronal damage and neuroinflammation., PMID:38104890

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant JEV Envelope protein E Protein, N-TrxA-His & C-His [YVV25701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only